Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response by Ryan J. Martinez & Brian D. Evavold
September 2015 | Volume 6 | Article 4681
Review
published: 10 September 2015
doi: 10.3389/fimmu.2015.00468
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Eric Huseby, 




University of Texas MD Anderson 
Cancer Center, USA 
Brian M. Baker, 
University of Notre Dame, USA
*Correspondence:
 Brian D. Evavold, 
Department of Microbiology and 
Immunology, Emory University, 
1510 Clifton Road NE, Room 3127, 
Atlanta, GA 30322, USA 
bevavol@emory.edu
Specialty section: 
This article was submitted to T Cell 






Martinez RJ and Evavold BD (2015) 
Lower affinity T cells are critical 
components and active participants 
of the immune response. 
Front. Immunol. 6:468. 
doi: 10.3389/fimmu.2015.00468
Lower affinity T cells are critical 
components and active participants 
of the immune response
Ryan J. Martinez and Brian D. Evavold *
Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA
Kinetic and biophysical parameters of T cell receptor (TCR) and peptide:MHC (pMHC) 
interaction define intrinsic factors required for T cell activation and differentiation. 
Although receptor ligand kinetics are somewhat cumbersome to assess experimentally, 
TCR:pMHC affinity has been shown to predict peripheral T cell functionality and potential 
for forming memory. Multimeric forms of pMHC monomers have often been used to 
provide an indirect readout of higher affinity T cells due to their availability and ease of use 
while allowing simultaneous definition of other functional and phenotypic characteristics. 
However, multimeric pMHC reagents have introduced a bias that underestimates the 
lower affinity components contained in the highly diverse TCR repertoires of all polyclonal 
T cell responses. Advances in the identification of lower affinity cells have led to the 
examination of these cells and their contribution to the immune response. In this review, 
we discuss the identification of high- vs. low-affinity T cells as well as their attributed 
signaling and functional differences. Lastly, mechanisms are discussed that maintain a 
diverse range of low- and high-affinity T cells.
Keywords: TCR affinity, 2D assays, tetramers, T cells, T cell diversity
introduction
The T cell immune response is composed of diverse sets of T cell receptors with a normally distributed 
range of affinities for pMHC (1, 2). Upon antigen recognition, the biophysical characteristics of the 
TCR:pMHC interaction will drive signaling, division, and differentiation (3, 4). Current hypotheses 
suggest the highest affinity T cells have a competitive advantage during the immune response, based 
on the assumption that they would receive stronger and more prolonged activation signals than T 
cells with lower affinity interactions (5–7). However, evidence is emerging to suggest the lack of 
skewing toward the highest affinity T cell repertoire, instead of proposing a distribution of affinities 
and maintenance of diversity throughout the immune response (8, 9). This T cell diversity has been 
shown to be important for homeostasis of the immune system, but the process of maintaining affinity 
diversity is unclear. We further discuss factors that support and favor the survival of lower affinity T 
cells and, therefore, highlight the important contribution of low-affinity T cells and a broad affinity 
distribution in the immune response.
Measurement of TCR:pMHC Affinity
Affinity is defined as the probability of a receptor (TCR)–ligand (pMHC) interaction and is one 
of the most commonly used measurements to predict the T cell response to antigen. As with all 
September 2015 | Volume 6 | Article 4682
Martinez and Evavold Low-affinity T cell importance in the immune response
Frontiers in Immunology | www.frontiersin.org
receptor–ligand interactions, affinity, or the association con-
stant (Ka) is derived from the on-rate (kon) and off-rate (koff) of 
receptor–ligand equilibrium and is calculated independently of 
concentrations of ligand and receptor (affinity =  Ka =  kon/koff) 
(Table  1) (3, 10). The affinity of an interaction is not its bond 
strength, or the force needed to break the bond, though these 
terms are often incorrectly used interchangeably. An example of 
this distinction can be seen in the avidin/biotin system as this 
receptor–ligand pair has one of the highest affinity interactions 
measured, but the non-covalent interactions can be easily broken, 
signifying lower bond strength (11). Along with TCR:pMHC 
affinity, the dissociation constant (Kd, inverse of Ka) and half-life 
[τ1/2 =  ln(2)/koff] can also be derived. The combination of these 
measurements have been used to describe T cell activation and 
differentiation models (kinetic proofreading, optimal dwell time, 
etc.), but not all methods of biophysical measurements generate 
similar results (3, 12, 13). Therefore, further understanding of 
measurement systems is necessary.
Affinity is commonly measured using purified reactants in 
solution by surface plasmon resonance (SPR), where free ligand 
is flowed over receptors fixed to a surface. This absolute affinity 
measurement occurs in three dimensions (3D) and allows for the 
definition of protein interactions in their simplest, purified form 
with no influence from outside forces. However, the increased 
degrees of freedom that occur in solution may not be the opti-
mal method to accurately assess interactions between receptor 
and ligands that occur in two opposing plasma membranes. A 
better replicate of in  vivo interactions between proteins at the 
membrane surface can be accomplished using two-dimensional 
(2D) receptor–ligand binding techniques, such as flow chamber 
assays, thermal fluctuation assays, single molecule FRET, Zhu–
Golan plots, contact area FRAP, and the adhesion frequency assay 
TABLe 1 | Definitions of biophysical parameters of TCR:pMHC 
interaction.
Keyword Definition
Affinity Tendency of association between a monovalent  
receptor–ligand pair at equilibrium. Two types of affinity 
measurements can be appreciated
Absolute affinity: affinity measurement using purified receptor 
and ligand without cellular context
Relative affinity: affinity measurement of receptor–ligand 
interactions in cellular membranes to recapitulate native 
interactions
Avidity Tendency of association between multivalent entities at 
equilibrium. This is not the sum of affinities as the binding of 
one receptor–ligand pair increases the likelihood of another 








The equilibrium constant of the dissociation of a  
receptor–ligand interaction
On-rate (kon) The rate at which a receptor and ligand bind to form a complex
Off-rate (koff) The rate at which a receptor–ligand complex reverses binding
Half-life (τ1/2) The amount of time needed for half of the receptor–ligand 
complexes to reverse binding
(3). Currently, the focus of our lab has been the use of the two-
dimensional micropipette adhesion frequency assay (2D-MP), a 
measurement of the relative 2D affinity of the receptor–ligand 
interaction on opposing membranes (14). This 2D affinity is 
termed a relative affinity because it is dependent on the context 
in which it was measured, whereas 3D methods generate an 
absolute affinity measurement while ignoring all other cellular 
participants. This distinction of relative and absolute affinity will 
be discussed in a later section. When 2D and 3D affinity TCR 
measurements are compared, an increased affinity with an associ-
ated decreased koff can be appreciated (12, 13, 15, 16). Attempts 
to correlate affinity values generated by 2D and 3D methods have 
been achieved with little success as the parameters controlling 
relative 2D affinity are still unknown (12). Importantly, the rela-
tive affinity measured by 2D-MP better correlates with functional 
responses than 3D methods and refers to the affinity in the proper 
cellular context (12, 15).
The advent of recombinant pMHC tetramer reagents has 
allowed for the identification of antigen-specific T cells and 
the subsequent use of these reagents for indirect assessment 
of biophysical interactions of TCR:pMHC. The binding of the 
tetramer reagent is dependent on valency to increase its avidity 
as monomeric pMHC complexes do not attach well to TCR (17, 
18). This lack of monomer interaction with TCR is most likely 
due to the reliance of pMHC tetramer staining on higher affinity 
interactions (8, 9). The koff and kon for each arm of the pMHC 
tetramer binding to TCRs are known to reflect avidity interac-
tions, with the binding of one pMHC monomer arm enhancing 
the kon of the subsequent monomer arm and reducing the koff of 
the entire reagent (19). The use of pMHC tetramer to measure koff, 
kon, and τ1/2 assumes that the amount of pMHC tetramer bound to 
a cell is directly proportional to the affinity of that cell, with more 
tetramer bound to higher affinity cells than to lower affinity T 
cells (6, 9, 19, 20). However, this assumption may not always yield 
a direct correlation, with many groups demonstrating tetramer 
binding intensity does not equate to functional responses or SPR 
measurements (21–24). One possible explanation for discrepan-
cies with SPR is that the cellular membrane can affect tetramer 
binding. Another possibility for these discrepancies is that 
TCR density affects binding because tetramer relies on avidity 
interactions. While many have normalized the TCR to pMHC 
concentrations on each cell (18, 25, 26), others do not account 
for the number of TCRs expressed at the cell surface (21, 27, 28). 
The effect of TCR density can be appreciated as the analysis of 
the tetramer+ populations reveals lower TCR expression as they 
exhibit only 20–40% of the TCR density compared to the bulk 
T cell population (unpublished data). This indicates tetramer+ 
T cells may have different TCR levels than the remaining T cell 
population but it is unknown if this is a cause or an effect of being 
a tetramer binder.
The measurement of TCR:pMHC affinity by 2D-MP is an 
extremely sensitive method that follows first-order kinetics 
and is dependent upon T cell intrinsic factors (3). Measured 
TCR affinities can be altered when reagents are used to change 
lipid composition and actin cytoskeleton (12). Adjustments 
of the membrane and supporting scaffolding should change 
2D affinity as the characteristics of the opposing membranes 
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during receptor–ligand interactions are fundamental for the 
measurement of relative 2D affinities. Much of the sensitivity 
of the 2D-MP assay comes from the flexibility of the red blood 
cell (RBC) membrane, which can be distended by the formation 
of a single TCR:pMHC bond (3, 29). As biotinylated pMHC is 
bound to the RBC through streptavidin interactions, clustering 
and valency of ligand could play a role in binding. Varying the 
concentration of pMHC on the RBC surface does not change the 
calculated affinity of activated T cells, signifying concentration 
does not affect the 2D measurements (12, 14). In experiments 
altering the valency of pMHC on the RBC through use of mutant 
streptavidin, no changes in 2D affinity were noted (12). This is in 
contrast to pMHC tetramers, which rely on both concentration 
and valency of the reagent to measure antigen specificity (30). 
Together, this suggests concentration and valency do not play 
a role in the measurement of affinity by 2D-MP. In addition, it 
demonstrates the micropipette values are a measure of affinity 
and not avidity.
An important distinction between CD4 and CD8 T cells is 
the contribution of coreceptor to the overall strength of binding 
between pMHC and TCR (18, 31). CD4 and CD8 coreceptors are 
thought to stabilize TCR:pMHC bonds while also recruiting Lck 
to the TCR complex for the initiation of the downstream signal-
ing cascade (32, 33). Intriguingly, CD8 has a higher affinity for 
its coreceptor than CD4, though both interactions are of weaker 
affinity (13, 32). For CD8 T cells, coreceptor contributes to the 
binding of TCR to pMHC when assessed by pMHC tetramer, 
2D-MP, and SPR (31, 34–36). The removal of CD8 contribution 
leads to decreased avidity and functional responses (37–39). In 
addition, the binding of the lowest affinity T cells are the most 
affected by the loss of CD8, signifying CD8 helps to increase the 
likelihood of low-affinity TCR:pMHC interaction and signaling 
(15, 37). In contrast, the role of CD4 is very different as there is lit-
tle to no contribution to the TCR:pMHC interaction as measured 
by 2D-MP, pMHC tetramer, and SPR (13, 32). This is not to say 
CD4 is not important in functional responses as CD4 is required 
to recruit Lck for optimal initiation of T cell signaling (17, 40, 
41), but at least under the conditions used in tetramer and 2D 
assays, there is little contribution to biophysical parameters (13). 
Importantly, detection of CD4 T cells by pMHCII tetramer would 
be expected to miss more of the lower affinity TCRs due to the 
lack of coreceptor contribution as compared to pMHCI tetramer 
and CD8 T cells. These differences in CD4 and CD8 coreceptor 
binding impact the use of tetramers to count antigen-specific T 
cells as well as measuring the kinetic rates of the TCR:pMHC 
interaction.
Detection of Antigen-Specific T Cells
The identification of T cells is important as the biophysical 
TCR:pMHC interactions discussed are correlated with functional 
responses. The current gold standard for identifying antigen-
specific T cells are using either pMHC tetramer reagents or 
readouts of functional responses, but both are sub-optimal in 
identifying the true number of antigen-specific T cells (42–45). 
For example, not all T cells of the same specificity make cytokine 
upon stimulation as demonstrated by the use of TCR-Tg T cells 
(46, 47). Further, a CD4 T population has a number of distinct 
fates with associated effector functions, such that any one cytokine 
will underestimate the total number of antigen-specific cells. 
Interestingly, the number of pMHC tetramer+ T cells sometimes 
equates to the number of cytokine-producing cells, even though 
not all T cells will produce the target cytokine (27, 43, 45). For 
the most part, intracellular staining for cytokines is incompatible 
with tetramer staining making it unclear if cytokine-producing 
cells overlap with tetramer binders, or if they are distinct popula-
tions. To more accurately identify the number of antigen-specific 
T cells, groups have used activation markers, such as CD11a, 
LFA-1, or CD49d, that are upregulated on antigen-specific T cells 
after infection (43, 48). When these cells are quantitated using 
these functional cell-surface markers, they far outnumber the 
number of tetramer or cytokine-producing cells (43, 48). The 
2D-MP further corroborates the underestimation of antigen-
specific T cells by pMHC tetramers (8, 9). When compared to 
the total population of antigen-specific T cells, pMHC tetramer+ 
T cells make up only the highest affinity population (9). Most T 
cell repertoires have a normally distributed TCR:pMHC affinity 
range, with the rarest cells being the highest and lowest affinity. 
Based on this data, tetramer+ cells are above average in affinity 
and would, therefore, only make up a fraction of the total T cells 
in an immune response (4). This would be especially apparent for 
CD4 T cells since the coreceptor does not aid in tetramer avidity.
The 2D-MP assay is currently the most sensitive available to 
capture the entire affinity range of a T cell repertoire and not just 
the highest affinity T cells. To perform the 2D-MP assay, single 
T cells are randomly chosen for affinity measurements from a 
purified population of cells. As this is a sampling process that 
is time intensive, it is important to understand the numbers of 
cells needed for analysis to reflect representative data of the entire 
population. To address how many cells need to be measured to 
find the average affinity of an antigen-specific polyclonal popula-
tion, we have combined previously published measurements of a 
polyclonal T cell population for a single antigen (MOG38–49:I-Ab) 
and performed random sampling experiments (Figure 1). When 
noting the moving average from 10 repetitions of the randomly 
sampled MOG-specific T cell affinities, it is apparent that the 
sampling affinity often reaches the average affinity rapidly, i.e., 
within 10 binding pairs. By the time, 16 binding T cells have been 
analyzed, the average affinity measured is ±5% of the affinity of 
the entire pooled population. This measurement is for a poly-
clonal population with a 2,000-fold range in affinity, meaning a 
repertoire with considerably less diversity (TCR-Tg or tetramer+ 
T cells) needs even fewer points measured to identify the average 
affinity. Therefore, to measure the average affinity of a normally 
distributed polyclonal repertoire only 10–16 T cell affinities need 
to be measured to be within 5% of the average affinity of the 
repertoire.
Signaling in Low-Affinity T Cells
In both kinetic-segregation and proofreading models, the bind-
ing of TCR:pMHC is key to activation, with the koff and kon and 
τ1/2 controlling the strength of signal the T cell receives (49–53). 
Higher affinity interactions with prolonged τ1/2 have an increased 
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likelihood of forming a stable conjugate and triggering the T 
cell signaling cascade, though an optimal τ1/2 most likely exists 
due to the hypothesized need for serial engagement (10, 50, 53). 
Using this logic, the lowest affinity T cells should have a reduced 
probability of initiating T cell signaling, but these cells do effi-
ciently propagate the signaling cascade as low-affinity T cells do 
expand, and differentiate during the immune response (8, 9, 48). 
Thus, mechanisms must exist that allow for low-affinity T cells, 
with the reduced probability of initial TCR:pMHC bond forma-
tion, to receive sufficient signals to compete with high-affinity 
counterparts.
Developing thymocytes discriminate positive- and negative-
selecting signals through both qualitative and quantitative 
signaling pathways. Qualitatively, studies have suggested that 
reduced but sustained Erk signaling is necessary for positive 
selection, while strong Erk, p38, and Jnk activation are necessary 
for negative selection (54–57). In positive selection, the protein 
Themis reduces TCR signaling by recruiting the phosphatase 
SHP-1 to inhibit Lck activation and reduces strong, transient, Erk 
activation, a property associated with negative selection (57, 58). 
Without Themis, low-affinity pMHC can produce strong agonist 
signals resulting in increased negative selection (58). This is of 
interest as negative regulatory mechanisms must be preventing 
low-affinity ligands from being selected like high-affinity ligands. 
Currently, it is unknown what controls the function of Themis or 
how it discriminates between high- and low-affinity pMHC to 
ultimately regulate downstream signals. One potential quantita-
tive mechanism for discriminating high- and low-affinity pMHC 
was found in thymocyte negative selection. During negative 
FiGURe 1 | Random sampling of measured TCR:pMHC reveals rapid 
approach to average affinity for an entire population. Previous 2D 
affinity measurements of MOG-specific CD4 T cells were combined and 
randomly arranged. A moving average was calculated and graphed as a 
function of the number of cells sampled. Cells were then randomly 
rearranged and moving average calculations were performed nine more times 
to generate the curves illustrated.
selection, thymocytes bind to pMHC and scan coreceptors (CD4 
and CD8) to find one coupled to Lck (59). CD8 coreceptors 
on thymocytes have a lower amount of coupled Lck than CD4 
coreceptor, so a longer TCR:pMHC τ1/2 is necessary for CD8 T 
cell negative selection (59). If a TCR:pMHC bond is maintained 
during the duration for a coreceptor-Lck conjugate to be found, 
the T cell is determined to be high affinity and will undergo Bim-
dependent apoptosis (60). These differences in signaling between 
positive and negative selection demonstrate how similar stimuli 
(pMHC) can generate distinct results depending on the TCR 
interaction parameters.
Naive CD4 and CD8 T cells demonstrate a distribution of 
reactivity to multiple foreign antigens that is established during 
thymic selection on self-antigens. In both naïve CD4 and CD8 T 
cells, multiple studies have been able to identify heterogeneity in 
reactivity of T cells for self- and foreign-pMHC (26, 61–64). These 
ranges of reactivity relate to markers of self-pMHC stimulation 
(CD5, Nur77, basal TCRζ phosphorylation) (26, 61, 64, 65) as well 
as indicators of activation in response to foreign-pMHC (ERK 
phosphorylation, IL-2 production) (64). Conflicting experimen-
tal evidence exists when attempting to correlate self-reactivity 
with foreign-reactivity (26, 61, 64). Some have demonstrated that 
CD5 positively correlates with foreign TCR reactivity (measured 
by pMHC tetramer and function) (26, 61), while others have 
demonstrated CD5 expression can be altered without changes 
to TCR affinity as measured by SPR (64). Nonetheless, based on 
the TCR affinity for self-pMHC, the immune system is able to 
diversify the reactivity of signaling machinery by controlling the 
basal phosphatase and kinase activity.
The first step of signaling after TCR triggering is phospho-
rylation of CD3 and TCRζ intracellular chains by Lck and the 
recruitment of the kinase Zap70. Phosphorylation of Zap70 by 
Lck propagates the initial signals and causes downstream activa-
tion of the MAP kinase (Erk), NF-κB, and calcineurin pathways 
(66). To inhibit signaling cascades, phosphatases, such as SHP-1/2 
and CD45, prevent the sustained activation of kinases (66). For 
low-affinity TCR:pMHC interactions, the peak of T cell signaling 
molecules (Erk, Jun, and Ras) are delayed or absent and TCR sign-
aling is decreased (58, 62, 67). This late and reduced activation of 
Erk in low-affinity T cells allows for the sustained recruitment and 
activity of SHP-1, decreasing the activation of Lck and reducing 
the T cell signaling response (58, 67, 68). Another phosphatase, 
PTPN22, has also been shown to inhibit Erk phosphorylation in 
T cells stimulated with low-affinity pMHC (69). It is surprising 
that even with these negative signaling events, low-affinity TCRs 
are able to signal and even upregulate activation genes CD69 and 
CD25 to similar levels as higher affinity T cells (7, 67). Similar to 
thymocyte selection, this demonstrates peripheral T cells have 
mechanisms to detect biophysical TCR interactions that can then 
be translated to signaling cascades as well as possess compensatory 
mechanisms to enhance low-affinity TCR interactions or even 
decrease higher affinity T cell interactions (70). Potentially, force 
generation by TCRs could be a mechanism by which low-affinity 
T cells are able to increase bond τ1/2 and receive similar signals as 
high-affinity counterparts (71–73). Conversely, it may be that dif-
ferent pathways are induced by low-affinity TCR:pMHC binding 
that are currently not understood. Overall, low- and high-affinity 
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T cells use similar mechanisms and machinery to signal, but the 
outcomes seem to vary in their response.
Functionality of Low-Affinity T Cells
The development and function of T cells has been highly associ-
ated with TCR:pMHC affinity, with high- and low-affinity T cell 
interactions often performing different roles. Thymocyte selec-
tion is dependent upon TCR:pMHC affinity interactions, with 
positive selection requiring low-affinity interactions and negative 
selection deleting thymocytes greater than a threshold affinity (1, 
74). The number of antigen-specific T cells for a single epitope 
is tightly controlled by central tolerance and, therefore, by TCRs 
affinity for self-pMHC presented in the thymus (75–79). The 
initial numbers of DP thymocytes for a single epitope are defined 
by the size of their positively selecting niche of self-peptides 
and further culled by their reactivity to self-antigen via nega-
tive selection (27, 63, 79–81). Work suggests positive selection 
is important in the generation of a functional T cell repertoire 
as alterations in the size of the selecting niche can cause T cell 
dysfunction or increased reactivity to antigen (63, 82). Analysis 
of the autoimmune prone NOD mouse has suggested its positive 
selecting niche is reduced, causing competition for positive selec-
tion survival signals and enriching for T cells that have a higher 
affinity TCR:self-pMHC interaction (81). This reduced positive 
selection niche and concurrent increase in TCR affinity will not 
be fully compensated by negative selection as negative selection 
is not as effective as once believed (63, 81, 83–85). The precursor 
frequency of a given antigen-specific T cell repertoire reproduc-
ibly generated by thymocyte selection is important as antigens 
with higher precursor frequencies can reach peak numbers more 
rapidly and provide better immune protection (27). Antigen-
specific T cell repertoires with lower precursor frequencies 
will have a greater fold expansion, but will still not outnumber 
the higher precursor frequency repertoires (86). Based on this 
functional data, one could assume that the repertoires with larger 
precursor frequency have a higher affinity for pMHC as this 
would mean they have undergone less negative selection. Recent 
work supports this hypothesis as epitopes with lower precursor 
frequency demonstrate more similarity to mouse self-peptides 
as well as reduced pMHCII tetramer binding (27). Therefore, a 
balance exists between positive and negative selection and their 
preference to favor low- and high-affinity interactions between 
pMHC and TCR will ultimately determine the numbers and 
affinity of antigen-specific T cells.
All the advantages of TCRs with high affinity for pMHC would 
suggest they can easily outcompete the lower affinity T cells (5), 
but this does not seem to be occurring when the full affinity rep-
ertoire is analyzed (8, 9, 48). One caveat to many model systems is 
the focus on a single TCR and the use of different APLs to model 
the fate of polyclonal T cells in response to lower affinity antigens 
(7, 59, 87–89). In TCR-Tg mice, each T cell undergoes similar 
thymic selection mechanisms, and therefore possesses similar 
reactivity to antigen. Groups have shown different repertoires 
undergo different TCR selection and peripheral tolerance mecha-
nisms, including negative selection, agonist selection, clonal 
diversion, and inhibitory molecule upregulation (65, 70, 74, 90, 
91). For example, every OT-I TCR-Tg T cell will be positively and 
negatively selected by the same self-antigens, while in a polyclonal 
system, T cells with a range of affinities will recognize the OT-I 
cognate peptide (SIINFEKL) and will be positively and negatively 
selected by numerous different peptides. In the polyclonal setting, 
there will be a range of affinities for SIINFEKL and an accom-
panying range of tolerance mechanisms to control responses to 
this antigen. Therefore, a single TCR binding to different affinity 
pMHC complexes during selection is not the same as a polyclonal 
set of different TCRs binding to a set of pMHC. This distinction 
between effects at a clonal as opposed to a polyclonal level could 
alter functionality and impact interpretation on the role of lower 
affinity ligands during an immune response.
After primary antigen exposure and triggering of signaling 
cascades, division of CD4 and CD8 T cells will cause 100- to 
1,000-fold expansion (61, 86, 92). Interestingly, low-affinity T cells 
are easily detectable throughout the response, signifying they are 
capable of expanding as well as high-affinity T cells (9, 48). Higher 
affinity CD8 TCR interactions cause asymmetric division that is 
associated with increased functionality of the proximal daughter 
cells (89). These CD8 T cells have similar initial rates of division, 
but eventually the highest affinity T cells maintain division while 
the lower affinity T cells begin to contract (7, 89). The contraction 
of lower affinity T cell is not due to increased death or lack of 
memory formation as a similar frequency of low-affinity pMHC 
primed CD8 T cells differentiates into memory T cells (88, 89). 
Along with differences in division rates, the migration kinetics 
of T cells are controlled by affinity, with the lower affinity APL 
stimulated T cells demonstrating increased numbers of TCR-Tg 
T cells in the blood at earlier time points (7). Studies in high- and 
low-affinity CD4 T cells demonstrates the time to the first divi-
sion of high-affinity CD4 T cells is much faster than low-affinity 
cells, though after several divisions, the low-affinity cells reach 
the same absolute number as high-affinity T cells (67). Together, 
these data demonstrate low- and high-affinity T cells behave 
similarly during initial expansion, but most likely have roles in 
the immune response at distinct times and locations.
Evidence demonstrates T cell affinity controls effector and 
memory differentiation of antigen-specific populations. Using 
the OT-I CD8 T cell APL system, groups have demonstrated 
low-affinity priming generates a greater frequency of Eomes+ 
memory T cells (88). It was determined that TGF-βR expression, 
a negative regulator of T cells, is not downregulated in low-affinity 
T cell responses, creating a balance of the generation (IL-12R) 
and ablation (TGF-βR) of memory T cells (88). In CD4 T cells, 
TCR:pMHC affinity has been correlated with memory (6, 93, 94), 
T helper subset (TH1 vs. TH2), and T follicular helper (TFH) dif-
ferentiation (92, 93, 95, 96) as well as prevention of exhaustion by 
chronic antigen exposure (97). Lower affinity TCR interactions 
have been shown to be biased to generate long-lived memory cells 
(6, 93, 94), while for TH1 vs. TH2 differentiation, greater strength 
of TCR stimulation increases the likelihood of TH1 differentiation 
(95, 96). For TFH cells, increased and decreased TCR:pMHC affin-
ity has been correlated with differentiation, thought to be due to 
TCR-dependent IL-2/IL-2R alterations (28, 92, 93). The finding 
that TFH cells can differentiate from TCRs with low and high-
affinity TCR:pMHC interactions is perplexing, but demonstrates 
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that active mechanisms maintain the differentiation diversity of 
the low and high-affinity T cells. Nonetheless, comparing and 
contrasting the findings of CD4 and CD8 T cells demonstrates 
the complexity of each system, but also demonstrates unique roles 
and pathways for high- and low-affinity TCR:pMHC interactions 
to presumably maintain functional diversity.
The activation and regulation of metabolic pathways is essen-
tial for the initiation and maintenance of the immune response 
(98–101). In CD8 T cells, the TCR:pMHC interaction controls 
initial metabolic reprograming by upregulating IRF4 and Myc in 
a TCR:pMHC affinity-dependent manner (101). The transcrip-
tion factors Myc and IRF4 coordinate the switch from fatty acid 
oxidation to aerobic glycolysis, which is essential for maintenance 
of the immune response (99, 101). Low-affinity TCR interactions 
led to less Myc and/or IRF4 expression, reducing the uptake 
of metabolic intermediates and changing the amount of T cell 
death during the response (99, 101). Therefore, TCR:pMHC 
affinity is necessary for instructing metabolic reprograming and 
a generating a greater functional response, but it is still unclear 
what function affinity-based metabolic reprograming plays for 
the differentiation and maintenance of low-affinity T cells.
Maintenance of Affinity Diversity
The maintenance of clonotype diversity in the immune system 
is essential for the health of the organism (102). By maintaining 
clonotype diversity, TCR affinity diversity is also preserved, with 
a single epitope being recognized by multiple T cells to create a 
normally distributed TCR:pMHC affinity population. For each 
epitope, a range of T cell precursors exist, whose frequency is 
controlled by central tolerance mechanisms (27, 103). As the 
preimmune frequency for a single epitope approaches 0, the 
capacity of the repertoire to protect the host from this epitope 
diminishes (90, 104). This theoretical lower limit of T cells that 
can effectively protect the host is defined as a protecton and is 
dependent upon the size of the organism and the migration 
velocity of T cells (105). Larger organisms need a larger protecton 
because their bodies have a greater volume to patrol and protect 
against pathogen dissemination.
Along with the size of the organism, the protecton is depend-
ent upon the amount of cross-reactivity between TCRs. To 
derive the level of cross-reactivity inherent to an individual’s 
TCRs, the entire number of antigen-specific T cells inclusive 
of lower affinity ones needs to be defined. Recent studies have 
identified T cells with cross-reactivity using multiple high-
affinity-dependent methodologies, such as pMHC tetramers, 
but the rules regulating cross-reactivity are still being formu-
lated (27, 104, 106, 107). Previous studies have suggested that the 
highest affinity T cells are the most cross-reactive as these cells 
have been shown to accept the most degeneracy in TCR:pMHC 
interaction and still function (108–110). However, single T cells 
can have both increased and decreased functional responses to 
peptides, meaning that just because a TCR binds to one pMHC 
with lower affinity, it cannot bind to another pMHC with 
higher affinity (106). Theoretically, a single TCR should possess 
a range of affinity for peptides presented by MHC, meaning 
that cross-reactivity is not unique to only high- or low-affinity 
TCRs. Groups have identified low-affinity T cells during the 
immune response, signifying these cells must be represented in 
the naïve mouse, yet these lower affinity T cells are currently 
not being included in the calculations (8, 9, 48). If inclusion of 
lower affinity T cells leads to a greater number of T cells in an 
antigen-specific repertoire, then the amount of cross-reactivity 
would correspondingly change (104). Therefore, protecton size 
and cross-reactivity calculations may be inaccurate due to the 
exclusion of these cells.
Low-affinity T cells are effective immune mediators and can 
have dominant roles in the immune response under specific con-
ditions (62, 88, 111–113). When T cell clones are compared for 
their ability to cause autoimmunity, combat infection, or prevent 
tumors, low-affinity T cells are often comparable in accomplishing 
these tasks (22, 62, 97, 112, 113). For example, when a lower affin-
ity CD8 T cell clone specific for an influenza antigen is transferred 
into a mouse expressing the antigen in a tumor, little immune 
response occurs (113). However, when this mouse is infected with 
influenza and/or given CD4 T cell help, the low-affinity T cells 
can respond with enhanced function (113). Along with influenza, 
groups have demonstrated adjuvants, such as CFA, MPL, and 
Listeria monocytogenes, can generate a larger population of low-
affinity T cells (6, 112, 114, 115). Besides adjuvants, the form of 
antigen can control low-affinity T cell expansion as the use of pro-
tein antigen has been demonstrated to recruit more low-affinity T 
cells into the immune response (94). Why antigen and adjuvant 
influence the affinity diversity of the T cell response is still unclear, 
though these factors point to the type of antigen presenting cells 
(APCs) as a possible manipulator of low- and high-affinity T cell 
skewing. This suggests high- and low-affinity T cells may compete 
for TCR signaling, but mechanism, such as antigen processing and 
presentation, may maintain and influence the affinity diversity.
Alteration of APC by using different adjuvants or forms of anti-
gen is one way to potentially alter T cell diversity, but can diversity 
of affinity be regulated in a T cell intrinsic fashion? As previously 
mentioned, the 2D affinity measurement by 2D-MP is a relative 
affinity, dependent unknown factors as well as the contact area 
restricting the receptor and ligand interactions. Our work reveals 
slightly different affinities (<10-fold) for thymocytes, peripheral 
naïve TCR-Tg T cells, and activated T cells demonstrating that 
the context of the membrane environments plays a role [(13) 
unpublished data]. Thymocytes, naïve, and activated T cells are 
different sizes, which may alter contact area between the T cell 
and RBC during the 2D-MP measurement. At the macroscopic 
level, the contact area difference between thymocytes and naïve 
T cells seems negligible, but in fact could result in differences 
as lymphocytes contain excess membranes, which is stored in 
ruffles and protrusions that could change during development 
and activation state (116). If there are differences in the ruffling 
of the membrane along with size differences, the membrane sur-
face area in contact containing the TCR and pMHC could vary 
between different populations of cells. Of note, within a given 
population of cells, the surface area would be similar allowing 
for accurate affinity measures. These effects on membrane surface 
would also be predicted to influence lymphocyte function in vivo, 
which could be why 2D affinity so accurately predicts the level of 
functional response.
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In addition, 2D affinities are dependent on the local membrane 
structure that is maintained by the actin cytoskeleton and con-
trolled by the membrane lipid composition. During TCR activa-
tion, the actin cytoskeleton is remodeled (117). This cytoskeleton 
change could alter the 2D-MP affinity as the integrity of the 
membrane structure and orientation of the surface proteins will 
also fundamentally change. Inhibition of actin polymerization 
has been demonstrated to reduce 2D affinity as well as functional 
responses (12, 13). The actin inhibitors again demonstrate how 
2D-affinity measurements accurately readout the functional-
ity of the TCR interaction with pMHC (12, 15). A T cell could 
manipulate its 2D affinity through changes in the cytoskeletal 
support and protein attachment to actin. Alternative 2D affinity 
could be regulated to a degree by alterations in lipid content as 
CD4 T cell subsets contain differential organization of lipids (118, 
119). Lipid composition has not been studied in relation to 2D 
affinity, but lipid order and organization has been demonstrated 
to be important in T cell functional responses, implicating the 
affinity may be different (118, 119).
Other surface proteins could influence the ability of the TCR 
to interact with pMHC and the 2D affinity. In the kinetic-segre-
gation model of T cell activation, the size of the CD45 molecule 
regulates the interaction of TCR:pMHC, with its exclusion from 
the synapse a necessary step to initiate the T cell signaling cascade 
(51, 52). T cell expression of a smaller isoform of CD45 would 
reduce steric hindrance and could increase the TCR:pMHC 
affinity measured by 2D-MP. Therefore, when the 2D affinity is 
calculated in the context of the cellular membrane, multiple T 
cell intrinsic factors can tune its measured value. In  vivo, this 
fine-tuning of 2D affinity could be envisioned as a mechanism 
allowing for small alterations in the likelihood of TCR engage-
ment (affinity for pMHC) while maintaining the diversity of the 
immune response.
Summary
Evidence demonstrates lower affinity T cells most likely have 
overlapping and distinct roles when compared to T cells with 
higher affinity interactions. Low-affinity T cells use much of the 
same signaling machinery for generating an immune response, 
but also must possess unique pathways or factors to sustain func-
tion and prevent excessive negative regulation during signaling. 
During differentiation, low-affinity T cells can again be found to 
have shared and unique roles when compared to higher affinity 
T cells. Low and high-affinity T cells must function together to 
efficiently generate a complete immune response and maintain 
the diversity of TCR affinity to efficiently protect the host.
Acknowledgments
The authors would like to thank Rakieb Andargachew, Dennis 
Neeld, Lori Blanchfield and Anna Kersh for helpful discussion.
This work was supported by NIH grant T32 AI007610, RO1 
NS071518, and RO1 AI110113 to BE and F31 NS086130 to RM.
References
 1. Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection 
of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 
(2014) 14:377–91. doi:10.1038/nri3667 
 2. Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring 
Harb Perspect Biol (2012) 4:a006957. doi:10.1101/cshperspect.a006957 
 3. Zhu C, Jiang N, Huang J, Zarnitsyna VI, Evavold BD. Insights from in situ 
analysis of TCR-pMHC recognition: response of an interaction network. 
Immunol Rev (2013) 251:49–64. doi:10.1111/imr.12016 
 4. Blanchfield JL, Shorter SK, Evavold BD. Monitoring the dynamics of T cell 
clonal diversity using recombinant peptide: MHC technology. Front Immunol 
(2013) 4:170. doi:10.3389/fimmu.2013.00170 
 5. Busch DH, Pamer EG. T cell affinity maturation by selective expan-
sion during infection. J Exp Med (1999) 189:701–10. doi:10.1084/
jem.189.4.701 
 6. Malherbe L, Hausl C, Teyton L, McHeyzer-Williams MG. Clonal selection of 
helper T cells is determined by an affinity threshold with no further skewing 
of TCR binding properties. Immunity (2004) 21:669–79. doi:10.1016/j.
immuni.2004.09.008 
 7. Zehn D, Lee SY, Bevan MJ. Complete but curtailed T-cell response to very 
low-affinity antigen. Nature (2009) 458:211–4. doi:10.1038/nature07657 
 8. Kersh AE, Edwards LJ, Evavold BD. Progression of relapsing-remitting 
demyelinating disease does not require increased TCR affinity or epitope 
spread. J Immunol (2014) 193:4429–38. doi:10.4049/jimmunol.1401456 
 9. Sabatino JJ, Huang J, Zhu C, Evavold BD. High prevalence of low affinity 
peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell 
responses. J Exp Med (2011) 208:81–90. doi:10.1084/jem.20101574 
 10. Stone JD, Kranz DM. Role of T cell receptor affinity in the efficacy and spec-
ificity of adoptive T cell therapies. Front Immunol (2013) 4:244. doi:10.3389/
fimmu.2013.00244 
 11. Kuo SC, Lauffenburger DA. Relationship between receptor/ligand binding 
affinity and adhesion strength. Biophys J (1993) 65:2191–200. doi:10.1016/
S0006-3495(93)81277-3 
 12. Huang J, Zarnitsyna VI, Liu B, Edwards LJ, Jiang N, Evavold BD, et al. The 
kinetics of two-dimensional TCR and pMHC interactions determine T-cell 
responsiveness. Nature (2010) 464:932–6. doi:10.1038/nature08944 
 13. Huppa JB, Axmann M, Mörtelmaier MA, Lillemeier BF, Newell EW, 
Brameshuber M, et al. TCR-peptide-MHC interactions in situ show accel-
erated kinetics and increased affinity. Nature (2010) 463:963–7. doi:10.1038/
nature08746 
 14. Chesla SE, Selvaraj P, Zhu C. Measuring two-dimensional receptor-ligand 
binding kinetics by micropipette. Biophys J (1998) 75:1553–72. doi:10.1016/
S0006-3495(98)74074-3 
 15. Liu B, Zhong S, Malecek K, Johnson LA, Rosenberg SA, Zhu C, et al. 2D TCR-
pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific 
TCR system. Eur J Immunol (2014) 44:239–50. doi:10.1002/eji.201343774 
 16. Adams JJ, Narayanan S, Liu B, Birnbaum ME, Kruse AC, Bowerman NA, et al. 
T cell receptor signaling is limited by docking geometry to peptide- major 
histocompatibility complex. Immunity (2011) 35:681–93. doi:10.1016/j.
immuni.2011.09.013 
 17. Hamad AR, O’Herrin SM, Lebowitz MS, Srikrishnan A, Bieler J, Schneck 
J, et  al. Potent T cell activation with dimeric peptide-major histocompati-
bility complex class II ligand: the role of CD4 coreceptor. J Exp Med (1998) 
188:1633–40. doi:10.1084/jem.188.9.1633 
 18. Crawford F, Kozono H, White J, Marrack P, Kappler J. Detection of anti-
gen-specific T cells with multivalent soluble class II MHC covalent peptide 
complexes. Immunity (1998) 8:675–82. doi:10.1016/S1074-7613(00)80572-5 
 19. Stone JD, Artyomov MN, Chervin AS, Chakraborty AK, Eisen HN, Kranz 
DM. Interaction of streptavidin-based peptide-MHC oligomers (tetramers) 
with cell-surface TCRs. J Immunol (2011) 187:6281–90. doi:10.4049/
jimmunol.1101734 
 20. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, 
Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 
(1996) 274:94–6. doi:10.1126/science.274.5284.94 
 21. Kim C, Wilson T, Fischer KF, Williams MA. Sustained interactions between 
T cell receptors and antigens promote the differentiation of CD4+ memory 
T cells. Immunity (2013) 39:508–20. doi:10.1016/j.immuni.2013.08.033 
September 2015 | Volume 6 | Article 4688
Martinez and Evavold Low-affinity T cell importance in the immune response
Frontiers in Immunology | www.frontiersin.org
 22. Dougan SK, Dougan M, Kim J, Turner JA, Ogata S, Cho H-I, et al. Transnuclear 
TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent 
anti-tumor activity. Cancer Immunol Res (2013) 1:99–111. doi:10.1158/2326-
6066.CIR-13-0047 
 23. al-Ramadi BK, Jelonek MT, Boyd LF, Margulies DH, Bothwell AL. Lack of 
strict correlation of functional sensitization with the apparent affinity of 
MHC/peptide complexes for the TCR. J Immunol (1995) 155:662–73. 
 24. Zhong S, Malecek K, Johnson LA, Yu Z, Vega-Saenz de Miera E, Darvishian 
F, et al. T-cell receptor affinity and avidity defines antitumor response and 
autoimmunity in T-cell immunotherapy. Proc Natl Acad Sci U S A (2013) 
110:6973–8. doi:10.1073/pnas.1221609110 
 25. Derby MA, Wang J, Margulies DH, Berzofsky JA. Two intermediate-avidity 
cytotoxic T lymphocyte clones with a disparity between functional avidity 
and MHC tetramer staining. Int Immunol (2001) 13:817–24. doi:10.1093/
intimm/13.6.817 
 26. Mandl JN, Monteiro JP, Vrisekoop N, Germain RN. T cell-positive selection 
uses self-ligand binding strength to optimize repertoire recognition of foreign 
antigens. Immunity (2013) 38:263–74. doi:10.1016/j.immuni.2012.09.011 
 27. Nelson RW, Beisang D, Tubo NJ, Dileepan T, Wiesner DL, Nielsen K, et al. 
T cell receptor cross-reactivity between similar foreign and self peptides 
influences naïve cell population size and autoimmunity. Immunity (2014) 
42(1):95–107. doi:10.1016/j.immuni.2014.12.022 
 28. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The 
function of follicular helper T cells is regulated by the strength of T cell anti-
gen receptor binding. Nat Immunol (2009) 10:375–84. doi:10.1038/ni.1704 
 29. Puech PH, Nevoltris D, Robert P, Limozin L, Boyer C, Bongrand P. Force 
measurements of TCR/pMHC recognition at T cell surface. PLoS One (2011) 
6(7):e22344. doi:10.1371/journal.pone.0022344 
 30. Chervin AS, Stone JD, Holler PD, Bai A, Chen J, Eisen HN, et al. The impact 
of TCR-binding properties and antigen presentation format on T cell respon-
siveness. J Immunol (2009) 183:1166–78. doi:10.4049/jimmunol.0900054 
 31. Daniels MA, Jameson SC. Critical role for CD8 in T cell receptor binding 
and activation by peptide/major histocompatibility complex multimers. J Exp 
Med (2000) 191:335–46. doi:10.1084/jem.191.2.335 
 32. Artyomov MN, Lis M, Devadas S, Davis MM, Chakraborty AK. CD4 and 
CD8 binding to MHC molecules primarily acts to enhance Lck delivery. Proc 
Natl Acad Sci U S A (2010) 107:16916–21. doi:10.1073/pnas.1010568107 
 33. Wooldridge L, van den Berg HA, Glick M, Gostick E, Laugel B, Hutchinson 
SL, et al. Interaction between the CD8 coreceptor and major histocompati-
bility complex class I stabilizes T cell receptor-antigen complexes at the cell 
surface. J Biol Chem (2005) 280:27491–501. doi:10.1074/jbc.M500555200 
 34. Jiang N, Huang J, Edwards LJ, Liu B, Zhang Y, Beal CD, et  al. Two-stage 
cooperative T cell receptor-peptide major histocompatibility complex-CD8 
trimolecular interactions amplify antigen discrimination. Immunity (2011) 
34:13–23. doi:10.1016/j.immuni.2010.12.017 
 35. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, 
et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule 
complexes. Nature (1996) 384:356–8. doi:10.1038/384577a0 
 36. Wyer JR, Willcox BE, Gao GF, Gerth UC, Davis SJ, Bell JI, et  al. T cell 
receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently 
and with distinct kinetics. Immunity (1999) 10:219–25. doi:10.1016/
S1074-7613(00)80022-9 
 37. Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells 
without selection of higher affinity TCR. Nat Immunol (2001) 2:711–7. 
doi:10.1038/90650 
 38. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/
pepMHC affinity and CD8 to T cell activation. Immunity (2003) 18:255–64. 
doi:10.1016/S1074-7613(03)00019-0 
 39. Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, et al. 
Different T cell receptor affinity thresholds and CD8 coreceptor dependence 
govern cytotoxic T lymphocyte activation and tetramer binding properties. 
J Biol Chem (2007) 282:23799–810. doi:10.1074/jbc.M700976200 
 40. Harding S, Lipp P, Alexander DR. A therapeutic CD4 monoclonal antibody 
inhibits TCR-zeta chain phosphorylation, zeta-associated protein of 70-kDa 
Tyr319 phosphorylation, and TCR internalization in primary human T cells. 
J Immunol (2002) 169:230–8. doi:10.4049/jimmunol.169.1.230 
 41. Pullar CE, Morris PJ, Wood KJ. Altered proximal T-cell receptor signalling 
events in mouse CD4+ T cells in the presence of anti-CD4 monoclonal 
antibodies: evidence for reduced phosphorylation of Zap-70 and LAT. Scand 
J Immunol (2003) 57:333–41. doi:10.1046/j.1365-3083.2003.01241.x 
 42. Kamperschroer C, Quinn DG. Quantification of epitope-specific MHC class-
II-restricted T cells following lymphocytic choriomeningitis virus infection. 
Cell Immunol (1999) 193:134–46. doi:10.1006/cimm.1999.1458 
 43. Harrington LE, Most Rv RV, Whitton JL, Ahmed R. Recombinant vaccinia 
virus-induced T-cell immunity: quantitation of the response to the virus 
vector and the foreign epitope. J Virol (2002) 76:3329–37. doi:10.1128/
JVI.76.7.3329-3337.2002 
 44. Varga SM, Welsh RM. Detection of a high frequency of virus-specific CD4+ 
T cells during acute infection with lymphocytic choriomeningitis virus. 
J Immunol (1998) 161:3215–8. 
 45. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJD, Zajac AJ, Miller 
JD, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander 
activation during viral infection. Immunity (1998) 8:177–87. doi:10.1016/
S1074-7613(00)80470-7 
 46. Williams MA, Ravkov EV, Bevan MJ. Rapid culling of the CD4+ T cell reper-
toire in the transition from effector to memory. Immunity (2008) 28:533–45. 
doi:10.1016/j.immuni.2008.02.014 
 47. Martinez RJ, Zhang N, Thomas SR, Nandiwada SL, Jenkins MK, Binstadt 
BA, et al. Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi 
anergic state in the presence of Foxp3+ regulatory T cells. J Immunol (2012) 
188:170–81. doi:10.4049/jimmunol.1101311 
 48. McDermott DS, Varga SM. Quantifying antigen-specific CD4 T cells during 
a viral infection: CD4 T cell responses are larger than we think. J Immunol 
(2011) 187:5568–76. doi:10.4049/jimmunol.1102104 
 49. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor 
number and tunable thresholds. Science (1996) 273:104–6. doi:10.1126/
science.273.5271.104 
 50. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering 
of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 
375:148–51. doi:10.1038/375148a0 
 51. Davis SJ, van der Merwe PA. The kinetic-segregation model: TCR triggering 
and beyond. Nat Immunol (2006) 7:803–9. doi:10.1038/ni1369 
 52. Anton van der Merwe P, Davis SJ, Shaw AS, Dustin ML. Cytoskeletal polar-
ization and redistribution of cell-surface molecules during T cell antigen 
recognition. Semin Immunol (2000) 12:5–21. doi:10.1006/smim.2000.0203 
 53. Kalergis AM, Boucheron N, Doucey MA, Palmieri E, Goyarts EC, Vegh Z, 
et al. Efficient T cell activation requires an optimal dwell-time of interaction 
between the TCR and the pMHC complex. Nat Immunol (2001) 2:229–34. 
doi:10.1038/85286 
 54. Sugawara T, Moriguchi T, Nishida E, Takahama Y. Differential roles of ERK 
and p38 MAP kinase pathways in positive and negative selection of T lym-
phocytes. Immunity (1998) 9:565–74. doi:10.1016/S1074-7613(00)80639-1 
 55. Mariathasan S, Zakarian A, Bouchard D, Michie AM, Zuniga-Pflucker JC, 
Ohashi PS. Duration and strength of extracellular signal-regulated kinase 
signals are altered during positive versus negative thymocyte selection. 
J Immunol (2001) 167:4966–73. doi:10.4049/jimmunol.167.9.4966 
 56. Fischer AM, Katayama CD, Pagès G, Pouysségur J, Hedrick SM. The role of 
Erk1 and Erk2 in multiple stages of T cell development. Immunity (2005) 
23:431–43. doi:10.1016/j.immuni.2005.08.013 
 57. McNeil LK, Starr TK, Hogquist KA. A requirement for sustained ERK 
signaling during thymocyte positive selection in vivo. Proc Natl Acad Sci U S 
A (2005) 102:13574–9. doi:10.1073/pnas.0505110102 
 58. Fu G, Casas J, Rigaud S, Rybakin V, Lambolez F, Brzostek J, et al. Themis sets 
the signal threshold for positive and negative selection in T-cell development. 
Nature (2013) 504:441–5. doi:10.1038/nature12718 
 59. Stepanek O, Prabhakar AS, Osswald C, King CG, Bulek A, Naeher D, et al. 
Coreceptor scanning by the T cell receptor provides a mechanism for T cell 
tolerance. Cell (2014) 159:333–45. doi:10.1016/j.cell.2014.08.042 
 60. Stritesky GL, Xing Y, Erickson JR, Kalekar LA, Wang X, Mueller DL, et al. 
Murine thymic selection quantified using a unique method to capture 
deleted T cells. Proc Natl Acad Sci U S A (2013) 110:4679–84. doi:10.1073/
pnas.1217532110 
 61. Fulton RB, Hamilton SE, Xing Y, Best JA, Goldrath AW, Hogquist KA, et al. 
The TCR’s sensitivity to self peptide–MHC dictates the ability of naive CD8+ 
T cells to respond to foreign antigens. Nat Immunol (2014) 16:107–17. 
doi:10.1038/ni.3043 
September 2015 | Volume 6 | Article 4689
Martinez and Evavold Low-affinity T cell importance in the immune response
Frontiers in Immunology | www.frontiersin.org
 62. Bettini M, Blanchfield L, Castellaw A, Zhang Q, Nakayama M, Smeltzer 
MP, et  al. TCR affinity and tolerance mechanisms converge to shape T 
cell diabetogenic potential. J Immunol (2014) 193:571–9. doi:10.4049/
jimmunol.1400043 
 63. Xing Y, Jameson SC, Hogquist KA. Thymoproteasome subunit-β5T generates 
peptide-MHC complexes specialized for positive selection. Proc Natl Acad Sci 
U S A (2013) 110:6979–84. doi:10.1073/pnas.1222244110 
 64. Persaud SP, Parker CR, Lo W-L, Weber KS, Allen PM. Intrinsic CD4+ T cell 
sensitivity and response to a pathogen are set and sustained by avidity for 
thymic and peripheral complexes of self peptide and MHC. Nat Immunol 
(2014) 15:266–74. doi:10.1038/ni.2822 
 65. Hogquist KA, Jameson SC. The self-obsession of T cells: how TCR signaling 
thresholds affect fate “decisions” and effector function. Nat Immunol (2014) 
15:815–23. doi:10.1038/ni.2938 
 66. Brownlie RJ, Zamoyska R. T cell receptor signalling networks: branched, 
diversified and bounded. Nat Rev Immunol (2013) 13:257–69. doi:10.1038/
nri3403 
 67. Rosenthal KM, Edwards LJ, Sabatino JJ, Hood JD, Wasserman HA, Zhu 
C, et al. Low 2-dimensional CD4 T cell receptor affinity for myelin sets in 
motion delayed response kinetics. PLoS One (2012) 7:e32562. doi:10.1371/
journal.pone.0032562 
 68. Stefanová I, Hemmer B, Vergelli M, Martin R, Biddison WE, Germain RN. 
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 
negative feedback pathways. Nat Immunol (2003) 4:248–54. doi:10.1038/
ni895 
 69. Salmond RJ, Brownlie RJ, Morrison VL, Zamoyska R. The tyrosine phos-
phatase PTPN22 discriminates weak self peptides from strong agonist TCR 
signals. Nat Immunol (2014) 15:875–83. doi:10.1038/ni.2958 
 70. Hebeisen M, Baitsch L, Presotto D, Baumgaertner P, Romero P, Michielin 
O, et  al. SHP-1 phosphatase activity counteracts increased T cell receptor 
affinity. J Clin Invest (2013) 123:1044–65. doi:10.1172/JCI65325 
 71. Liu B, Chen W, Evavold BD, Zhu C. Accumulation of dynamic catch bonds 
between TCR and agonist peptide-MHC triggers T cell signaling. Cell (2014) 
157:357–68. doi:10.1016/j.cell.2014.02.053 
 72. Kumar D, Feng Y, Mallis RJ, Li X, Keskin DB, Hussey RE, et  al. Force-
dependent transition in the T-cell receptor β-subunit allosterically regulates 
peptide discrimination and pMHC bond lifetime. Proc Natl Acad Sci U S A 
(2015) 112:1517–22. doi:10.1073/pnas.1424829112 
 73. Husson J, Chemin K, Bohineust A, Hivroz C, Henry N. Force generation 
upon T cell receptor engagement. PLoS One (2011) 6:e19680. doi:10.1371/
journal.pone.0019680 
 74. Stritesky GL, Jameson SC, Hogquist KA. Selection of self-reactive T 
cells in the thymus. Annu Rev Immunol (2012) 30:95–114. doi:10.1146/
annurev-immunol-020711-075035 
 75. Jenkins MK, Moon JJ. The role of naive T cell precursor frequency and 
recruitment in dictating immune response magnitude. J Immunol (2012) 
188:4135–40. doi:10.4049/jimmunol.1102661 
 76. Chu HH, Moon JJ, Takada K, Pepper M, Molitor JA, Schacker TW, et  al. 
Positive selection optimizes the number and function of MHCII-restricted 
CD4+ T cell clones in the naive polyclonal repertoire. Proc Natl Acad Sci U S 
A (2009) 106:11241–5. doi:10.1073/pnas.0902015106 
 77. Moon JJ, Chu HH, Pepper M, McSorley SJ, Jameson SC, Kedl RM, et  al. 
Naive CD4(+) T cell frequency varies for different epitopes and predicts 
repertoire diversity and response magnitude. Immunity (2007) 27:203–13. 
doi:10.1016/j.immuni.2007.07.007 
 78. Jenkins MK, Chu HH, McLachlan JB, Moon JJ. On the composition of the 
preimmune repertoire of T cells specific for peptide-major histocompati-
bility complex ligands. Annu Rev Immunol (2010) 28:275–94. doi:10.1146/
annurev-immunol-030409-101253 
 79. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. 
T cell receptor antagonist peptides induce positive selection. Cell (1994) 
76:17–27. doi:10.1016/0092-8674(94)90169-4 
 80. Merkenschlager M, Benoist C, Mathis D. Evidence for a single-niche model of 
positive selection. Proc Natl Acad Sci U S A (1994) 91:11694–8. doi:10.1073/
pnas.91.24.11694 
 81. Mingueneau M, Jiang W, Feuerer M, Mathis D, Benoist C. Thymic neg-
ative selection is functional in NOD mice. J Exp Med (2012) 209:623–37. 
doi:10.1084/jem.20112593 
 82. Ignatowicz L, Kappler J, Marrack P. The repertoire of T cells shaped 
by a single MHC/peptide ligand. Cell (1996) 84:521–9. doi:10.1016/
S0092-8674(00)81028-4 
 83. Taniguchi RT, DeVoss JJ, Moon JJ, Sidney J, Sette A, Jenkins MK, et  al. 
Detection of an autoreactive T-cell population within the polyclonal 
repertoire that undergoes distinct autoimmune regulator (Aire)-mediated 
selection. Proc Natl Acad Sci U S A (2012) 109(20):7847–52. doi:10.1073/
pnas.1120607109 
 84. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates 
negative selection of organ-specific T cells. Nat Immunol (2003) 4:350–4. 
doi:10.1038/ni906 
 85. Yu W, Jiang N, Ebert PJR, Kidd BA, Muller S, Lund PJ, et al. Clonal deletion 
prunes but does not eliminate self-specific alpha beta CD8+ T lymphocytes. 
Immunity (2015) 42:929–41. doi:10.1016/j.immuni.2015.05.001 
 86. Quiel J, Caucheteux S, Laurence A, Singh NJ, Bocharov G, Ben-Sasson SZ, 
et al. Antigen-stimulated CD4 T-cell expansion is inversely and log-linearly 
related to precursor number. Proc Natl Acad Sci U S A (2011) 108:3312–7. 
doi:10.1073/pnas.1018525108 
 87. Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen 
routinely evade central and peripheral tolerance and cause autoimmunity. 
Immunity (2006) 25:261–70. doi:10.1016/j.immuni.2006.06.009 
 88. Knudson K, Goplen N, Cunningham C, Daniels M, Teixeiro E. Low-affinity 
T cells are programmed to maintain normal primary responses but are 
impaired in their recall to low-affinity ligands. Cell Rep (2013) 4:554–65. 
doi:10.1016/j.celrep.2013.07.008 
 89. King CG, Koehli S, Hausmann B, Schmaler M, Palmer E. T cell affinity reg-
ulates asymmetric division, effector cell differentiation, and tissue pathology. 
Immunity (2013) 37:709–20. doi:10.1016/j.immuni.2012.06.021 
 90. Vrisekoop N, Monteiro JP, Mandl JN, Germain RN. Revisiting thymic posi-
tive selection and the mature T cell repertoire for antigen. Immunity (2014) 
41:181–90. doi:10.1016/j.immuni.2014.07.007 
 91. Lee H-M, Bautista JL, Scott-Browne J, Mohan JF, Hsieh C-S. A broad range 
of self-reactivity drives thymic regulatory T cell selection to limit responses 
to self. Immunity (2012) 37:475–86. doi:10.1016/j.immuni.2012.07.009 
 92. Tubo NJ, Pagán AJ, Taylor JJ, Nelson RW, Linehan JL, Ertelt JM, et  al. 
Single naive CD4(+) T cells from a diverse repertoire produce different 
effector cell types during infection. Cell (2013) 153:785–96. doi:10.1016/j.
cell.2013.04.007 
 93. Keck S, Schmaler M, Ganter S, Wyss L, Oberle S, Huseby ES, et  al. 
Antigen affinity and antigen dose exert distinct influences on CD4 T-cell 
differentiation. Proc Natl Acad Sci U S A (2014) 111:14852–7. doi:10.1073/
pnas.1403271111 
 94. Baumgartner CK, Yagita H, Malherbe LP. A TCR affinity threshold regulates 
memory CD4 T cell differentiation following vaccination. J Immunol (2012) 
189:2309–17. doi:10.4049/jimmunol.1200453 
 95. Van Panhuys N, Klauschen F, Germain RN. T-cell-receptor-dependent signal 
intensity dominantly controls CD4(+) T cell polarization in vivo. Immunity 
(2014) 41(1):63–74. doi:10.1016/j.immuni.2014.06.003 
 96. Brogdon JL, Leitenberg D, Bottomly K. The potency of tcr signaling differen-
tially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ 
T cells. J Immunol (2002) 168:3825–32. doi:10.4049/jimmunol.168.8.3825 
 97. Caserta S, Kleczkowska J, Mondino A, Zamoyska R. Reduced functional 
avidity promotes central and effector memory CD4 T cell responses to 
tumor-associated antigens. J Immunol (2010) 185:6545–54. doi:10.4049/
jimmunol.1001867 
 98. O’Sullivan D, van der Windt GJW, Huang SC-C, Curtis JD, Chang C-H, Buck 
MD, et  al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support 
the metabolic programming necessary for development. Immunity (2014) 
41:75–88. doi:10.1016/j.immuni.2014.06.005 
 99. Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The tran-
scription factor Myc controls metabolic reprogramming upon T lymphocyte 
activation. Immunity (2011) 35:871–82. doi:10.1016/j.immuni.2011.09.021 
 100. Van der Windt GJW, O’Sullivan D, Everts B, Huang SC-C, Buck MD, Curtis 
JD, et al. CD8 memory T cells have a bioenergetic advantage that underlies 
their rapid recall ability. Proc Natl Acad Sci U S A (2013) 110:14336–41. 
doi:10.1073/pnas.1221740110 
 101. Man K, Miasari M, Shi W, Xin A, Henstridge DC, Preston S, et  al. The 
transcription factor IRF4 is essential for TCR affinity-mediated metabolic 
September 2015 | Volume 6 | Article 46810
Martinez and Evavold Low-affinity T cell importance in the immune response
Frontiers in Immunology | www.frontiersin.org
programming and clonal expansion of T cells. Nat Immunol (2013) 14:1155–
65. doi:10.1038/ni.2710 
 102. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of 
T-cell repertoire diversity. Nat Rev Immunol (2004) 4:123–32. doi:10.1038/
nri1292 
 103. Moon JJ, Chu HH, Hataye J, Pagán AJ, Pepper M, McLachlan JB, et  al. 
Tracking epitope-specific T cells. Nat Protoc (2009) 4:565–81. doi:10.1038/
nprot.2009.9 
 104. Zarnitsyna VI, Evavold BD, Schoettle LN, Blattman JN, Antia R. Estimating 
the diversity, completeness, and cross-reactivity of the T cell repertoire. Front 
Immunol (2013) 4:485. doi:10.3389/fimmu.2013.00485 
 105. Langman RE, Cohn M. The E-T (elephant-tadpole) paradox necessitates 
the concept of a unit of B-cell function: the protection. Mol Immunol (1987) 
24:675–97. doi:10.1016/0161-5890(87)90050-2 
 106. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, 
Tan MP, et al. A single autoimmune T cell receptor recognizes more than a 
million different peptides. J Biol Chem (2012) 287:1168–77. doi:10.1074/jbc.
M111.289488 
 107. Birnbaum ME, Mendoza JL, Sethi DK, Dong S, Glanville J, Dobbins J, et al. 
Deconstructing the peptide-MHC specificity of T cell recognition. Cell 
(2014) 157:1073–87. doi:10.1016/j.cell.2014.03.047 
 108. Holler PD, Lim AR, Cho BK, Rund LA, Kranz DM. CD8(-) T cell transfectants 
that express a high affinity T cell receptor exhibit enhanced peptide-depen-
dent activation. J Exp Med (2001) 194:1043–52. doi:10.1084/jem.194.8.1043 
 109. Donermeyer DL, Weber KS, Kranz DM, Allen PM. The study of high-affinity 
TCRs reveals duality in T cell recognition of antigen: specificity and degen-
eracy. J Immunol (2006) 177:6911–9. doi:10.4049/jimmunol.177.10.6911 
 110. Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign 
pMHC show self-reactivity. Nat Immunol (2003) 4:55–62. doi:10.1038/ni863 
 111. O’Sullivan JA, Zloza A, Kohlhapp FJ, Moore TV, Lacek AT, Dulin NO, 
et  al. Priming with very low-affinity peptide ligands gives rise to CD8+ 
T-cell effectors with enhanced function but with greater susceptibility to 
transforming growth factor (TGF)β-mediated suppression. Cancer Immunol 
Immunother (2011) 60:1543–51. doi:10.1007/s00262-011-1043-1 
 112. Khan N, Cobbold M, Cummerson J, Moss PAH. Persistent viral infection in 
humans can drive high frequency low-affinity T-cell expansions. Immunology 
(2010) 131:537–48. doi:10.1111/j.1365-2567.2010.03326.x 
 113. Lyman MA, Nugent CT, Marquardt KL, Biggs JA, Pamer EG, Sherman LA. 
The fate of low affinity tumor-specific CD8+ T cells in tumor-bearing mice. 
J Immunol (2005) 174:2563–72. doi:10.4049/jimmunol.174.5.2563 
 114. Rees W, Bender J, Teague TK, Kedl RM, Crawford F, Marrack P, et al. An 
inverse relationship between T cell receptor affinity and antigen dose during 
CD4(+) T cell responses in vivo and in vitro. Proc Natl Acad Sci U S A (1999) 
96:9781–6. doi:10.1073/pnas.96.17.9781 
 115. Srinivasan A, Foley J, McSorley SJ. Massive number of antigen-specific 
CD4 T cells during vaccination with live attenuated Salmonella causes 
interclonal competition. J Immunol (2004) 172:6884–93. doi:10.4049/
jimmunol.172.11.6884 
 116. Majstoravich S, Zhang J, Nicholson-Dykstra S, Linder S, Friedrich W, 
Siminovitch KA, et  al. Lymphocyte microvilli are dynamic, actin-depen-
dent structures that do not require Wiskott-Aldrich syndrome protein 
(WASp) for their morphology. Blood (2004) 104:1396–403. doi:10.1182/
blood-2004-02-0437 
 117. Sechi AS, Wehland J. Interplay between TCR signalling and actin cytoskeleton 
dynamics. Trends Immunol (2004) 25:257–65. doi:10.1016/j.it.2004.03.003 
 118. Miguel L, Owen DM, Lim C, Liebig C, Evans J, Magee AI, et  al. Primary 
human CD4+ T cells have diverse levels of membrane lipid order that 
correlate with their function. J Immunol (2011) 186:3505–16. doi:10.4049/
jimmunol.1002980 
 119. Nagafuku M, Okuyama K, Onimaru Y, Suzuki A, Odagiri Y, Yamashita T, et al. 
PNAS plus: CD4 and CD8 T cells require different membrane gangliosides 
for activation. Proc Natl Acad Sci U S A (2012) 109:E336–42. doi:10.1073/
pnas.1114965109 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2015 Martinez and Evavold. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
